Presentation DIVES MED TREHFILL stands out as a cutting-edge hybrid tissue stimulator designed to deeply revitalize the skin. By combining poly-L-lactic acid with bioactive peptides, this innovative treatment works at the core of the dermis to restart natural regeneration processes. It provides a high-performance solution to correct volume loss and skin laxity, with long-lasting results.
Composition
& Rheology Poly-L-lactic acid (PLLA): 70 mg per 2 ml vial Bioactive peptides: supportive agents for cellular regeneration Cross-linking technology: OBT Format: 2 ml vial (microparticle suspension)
Indications
This device is specifically formulated to address signs of facial aging. It is ideal for redefining facial contours, filling hollow temples and cheeks, and softening nasolabial folds and marionette lines. It is also suitable for patients with moderate skin laxity seeking a natural tightening effect. Posology Administration must be performed by a qualified practitioner.
PLLA microparticles induce a targeted, mild inflammatory response that stimulates fibroblasts. Results develop gradually over a period of 4 to 6 weeks, with durability lasting up to 24 months following a complete protocol. Storage Store the vial in a cool, dry place, away from direct sunlight and extreme temperature variations.
Adhere to the storage conditions specified by the manufacturer. Contraindications Hypersensitivity to poly-L-lactic acid or peptides Active infection or inflammation in the treatment area Pregnant or breastfeeding women Patients with bleeding disorders or uncontrolled autoimmune diseases
FAQ
How long do the effects of the treatment last? Results are progressive and can be maintained for up to 24 months after completing the recommended protocol. How does PLLA affect the skin? Poly-L-lactic acid stimulates endogenous collagen production, naturally restoring skin firmness, volume, and elasticity.
